FDA clears GE's updated cardiac CT

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

GE Healthcare has received FDA 510(k) clearance of its new cardiac imaging platform, the Discovery CT750 HD FREEdom Edition.

Based on FREEdom technologies ( Fast Registered Energies & ECG), the Discovery CT750 HD FREEdom Edition is a three-prong technology, including: Motion FREEdom, with motion correction via SnapShot Freeze; Calcium FREEdom, with coronary visualization using Gemstone Spectral Imaging (GSI) Cardiac; and Horizon FREE opportunities, which provides plaque material composition assessment and perfusion calculations, the company said in its press release. 

GE said that the Discovery CT750 HD FREEdom Edition also merges GE’s SnapShot Pulse technology with GSI’s kV switching, allowing for a registered spectral CT dataset. And Calcium FREEdom means that coronary images with calcium suppression are possible for patients with high calcium burden.

The HD FREEdom Edition’s first U.S. installation was at the University of Washington (UW) in Seattle. HD FREEdom’s installation at UW follows around two dozen installations in Europe and Japan where physicians currently use SnapShot Freeze and GSI Cardiac in practice for coronary evaluation, and in plaque composition and myocardial perfusion assessment.